白癜风与显性甲状腺疾病的全国性人群研究
基于韩国国民健康保险理赔数据库,纳入73,336例白癜风患者及146,672例年龄性别匹配对照,发现白癜风患者显性Graves病、桥本甲状腺炎及甲状腺癌风险均升高,且男性及年轻患者关联更强。
要点
- 白癜风患者显性Graves病风险升高(OR 2.610)。
- 白癜风患者显性桥本甲状腺炎风险升高(OR 1.609)。
- 白癜风患者显性甲状腺癌风险轻度升高(OR 1.127)。
核心结论
- 白癜风与显性自身免疫性甲状腺疾病及显性甲状腺癌显著相关。
研究设计与样本
- 基于韩国国民健康保险理赔数据库的全国性人群研究,纳入73,336例白癜风患者及146,672例年龄性别匹配对照。
- 白癜风定义为2009至2013年间以白癜风为主要诊断且就诊≥4次的患者。
主要发现
- 白癜风患者相比对照的Graves病OR为2.610(95%CI 2.319-2.938)。
- 白癜风患者相比对照的桥本甲状腺炎OR为1.609(95%CI 1.437-1.802)。
- 白癜风患者相比对照的甲状腺癌OR为1.127(95%CI 1.022-1.242)。
- 上述关联在男性和年轻患者中一致更强。
关键数值与推荐
- 显性Graves病和桥本甲状腺炎定义为患者正在服用相关甲状腺药物。
- 甲状腺癌为感兴趣结局之一。
临床怎么用
- 对白癜风患者,尤其男性和年轻患者,应关注显性自身免疫性甲状腺疾病及甲状腺癌的筛查。
局限性
- 缺乏个体临床信息。
- 人群同质性可能限制结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Associations between vitiligo and thyroid diseases have been reported repeatedly. OBJECTIVE: We investigated the associations between vitiligo and overt autoimmune thyroid diseases and thyroid cancer using the Korean National Health Insurance claims database. METHODS: We defined patients with vitiligo as those whose records showed ≥4 physician contacts between 2009 and 2013 in which vitiligo was the principal diagnosis. We also established an age- and sex-matched control group without vitiligo (2 per 1 vitiligo patient). The outcomes of interest were concurrent Graves disease and Hashimoto thyroiditis (the patients were taking relevant thyroid medications) and thyroid cancer. RESULTS: The study enrolled 73,336 vitiligo patients and 146,672 controls. Patients with vitiligo were at increased risks of Graves disease (odds ratio [OR] 2.610 [95% confidence interval {CI} 2.319-02.938]), Hashimoto thyroiditis (OR 1.609 [95% CI 1.437-1.802]), and thyroid cancer (OR 1.127 [95% CI 1.022-1.242]), compared with the controls. The associations were consistently stronger in males and younger patients. LIMITATIONS: Individual clinical information was not available, and the homogeneous population may limit the generalizability of the results. CONCLUSION: Vitiligo was significantly associated with overt autoimmune thyroid diseases and overt thyroid cancer.
引用
- Bae JM, Lee JH, Yun JS, et al. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea. J Am Acad Dermatol. 2017. PMID: 28238453. doi:10.1016/j.jaad.2016.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。